Aligos Therapeutics, Inc. · NASDAQ:ALGS

Woodline Partners LP's stake in Aligos Therapeutics, Inc. fell to 4.40% (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

Woodline Partners LP's stake in Aligos Therapeutics, Inc. fell to 4.40%, 239,362 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
4.40%
Shares
239,362
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
Woodline Partners LP4.40%239,362

Source

View original at SEC

Related